Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-468-6 | CAS number: 107-15-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1987 or before
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 987
- Report date:
- 1987
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Principles of method if other than guideline:
- Salmonella typhimurium/ microsome mutagenicity assay.
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- Ethylenediamine
- EC Number:
- 203-468-6
- EC Name:
- Ethylenediamine
- Cas Number:
- 107-15-3
- Molecular formula:
- C2H8N2
- IUPAC Name:
- ethane-1,2-diamine
Constituent 1
Method
Species / strainopen allclose all
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Species / strain / cell type:
- S. typhimurium TA 1538
- Metabolic activation:
- with and without
- Metabolic activation system:
- S-9
- Test concentrations with justification for top dose:
- Without S9: 0, 0.01, 0.03, 0.1, 0.3 and 1 mg/plate; confirmatory study TA100 and TA1535: 0, 1, 3 and 5 mg/plate
With S9: 0, 0.1, 0.3, 1, 3 and 5 mg/plate; confirmatory study TA100 and TA1535: 0, 1, 2, 3, 4, 5 and 6 mg/plate - Vehicle / solvent:
- Distilled water
Controls
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- sodium azide
- other: 4-nitro-o-phenylenediamine, 2-aminoanthacene
- Details on test system and experimental conditions:
- A 100 ml sample of EDA was received for testing at BRRC on November 21, 1986. The sample was assigned the unique BRRC Sample Number of 49-428 and was stored at room temperature. Gas chromatographic analysis was performed by the sponsor indicated that the sample was 99.58% EDA.
The sample was completely soluble in water; thus, water was used as the solvent for dilution of the test agent. Dilutions were prepared fresh on the morning of each test day and the accuracy of dilution was verified by gravimetric analysis. The undiluted test agent and the test agent diluted in water were indicated by the sponsor to be stable and no stability testing was performed in the the test system.
Control Substances
1. Solvent: Water; BRRC #49-27; CAS #7732—18—5
2. Positive Controls: ‘
a) 4-nitro-o-phenylenediamine; BRRC #44—71; CAS #99—56-9
b) 9-aminoacridine; BRRC #44-233; CAS #90—45—9
c) sodium azide; BRRC #44—72; CAS #26625—22—8
d) 2-aminoanthracene; BRRC #44—67 and 50-168; GAS #613—13-8
Metabolic Activation
S9 liver homogenate, prepared from Aroclor 1254 induced, Sprague-Dawley male rats, was purchased from Microbiological Associates, Bethesda, MD. For tests with metabolic activation, 0.5 ml of $9 mix containing 50 pl of S9 was added per plate.
The assay was performed according to BRRC Standard Operating Procedures 7.4.1A through 7.4.7A, 7.4.12A, and 7.4.13.
Sample Preparation:
For definitive testing, an initial stock solution of the test substance was prepared by mixing EDA in water to achieve a concentration of 50 mg/ml. All subsequent dilutions were made in the same solvent. Dilutions of the test substance were made fresh each day of testing.
All dilutions for the mutagenicity tests were analysed gravimetrically to determine actual concentrations.
Dose Selection:
A preliminary toxicity test was performed using strain TA100 to determine the level of toxicity of the test substance. Ten doses were tested for toxicity with a plate assay performed in the manner used for mutagenicity determinations. Toxicity was assessed at 48 hours after treatment by observing growth inhibition of the background lawn and/or a reduction in the number of spontaneous mutants.
Testing:
The test chemical was tested in triplicate at five doses chosen to span a range which included moderately toxic to relatively nontoxic concentrations. Testing was performed both with and without metabolic activation. Concurrent solvent and positive controls were tested in each experiment.
Quality Control
Data from each test was checked for accuracy and integrity by a second investigator. Compliance of testing procedures with Good Laboratory Practices was audited by the independent Quality Assurance Unit at the Bushy Run Research Center. - Evaluation criteria:
- The spontaneous reversion for the solvent controls should be within this laboratory's historical range. The positive controls should demonstrate that the test systems are responsive with known mutagens. A test chemical is considered to be a bacterial mutagen if the number of revertant colonies is at least twice the solvent control for at least one dose level and there is evidence of a dose-related increase in the number of revertant colonies. If a test chemical produces a marginal or weak response that cannot be reproduced in a second test, the test result will be considered negative. If there is no evidence of a dose-related increase in the number of revertant colonies and the number of revertant colonies is not twice the solvent control, then the test chemical is not considered to be a bacterial mutagen.
- Statistics:
- No statistical analysis
Results and discussion
Test resultsopen allclose all
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 1538
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- Ambiguous results in strain TA100 with metabolic activation. Negative in all other strains.
Any other information on results incl. tables
Dose | Table 1 Ethylenediamine without S9 activation | ||||
mg/plate | TA98 | TA100 | TA1535 | TA1537 | TA1538 |
0 | 26+3.5 | 113+19.7 | 19+2.5 | 6 +3.1 | 8+2.5 |
0.01 | 23+9.6 | 112+7.0 | 21+5.7 | 6 +1.5 | 7+1.7 |
0.03 | 25 +3.1 | 119+13.9 | 17+10.5 | 5+1.5 | 10+5.0 |
0.1 | 28+2.9 | 136+26.3 | 27+1.5 | 6+1.5 | 9+4.7 |
0.3 | 32 +10.5 | 152+5.9 | 35+10.4 | 7 +2.5 | 11+4.5 |
1 | Toxic | Toxic/s | Toxic | Toxic | Toxic |
Pos Control | 1140+63.5 | 2554+115 | 2369+117 | 269+53.3 | 1470+102.4 |
4 -NPD | NaN3 | Na N3 | 9 -AA | 4 -NPD | |
Dose | Table 2 Ethylenediamine with S9 activation | ||||
mg/plate | TA98 | TA100 | TA1535 | TA1537 | TA1538 |
0 | 34+7.4 | 114+4.6 | 6+1.2 | 5+0.6 | 28+1.7 |
0.1 | 36+5.8 | 119+21.4 | 11+5.2 | 4+0.6 | 25+8.1 |
0.3 | 30+2.3 | 128+9.6 | 8+3.1 | 6+3.6 | 27+6.4 |
1 | 27+6.4 | 121+9.2 | 8+2.0 | 7+4.0 | 17+4.0 |
3 | 29+4.2T | 214+0.7S | 15+7.5 | 9+4.0 | 20+8.5 |
5 | 16+9.1T | 212+32.7 | 17+9.3 | 7+1.0 | 8+1.4S |
Pos Control | 1226 +249.5 | 818 +172.5 | 32 +8.7 | 49 +7.6 | 106 +15.5 |
2 -AA | 2 -AA | 2 -AA | 2 -AA | 2 -AA | |
Dose | Table 3 Ethylenediamine (repeat) without S9 activation | ||||
mg/plate | TA100 | TA1535 | |||
0 | 92+10.8 | 13+3.2 | |||
1 | 135+10.0 | 11+4.4 | |||
3 | 165+10.1 | 16+3.2 | |||
5 | 161+22.9 | 12+3.5S | |||
Pos Control | 940+152.0 | 42+7.4 | |||
2 -AA | 2 -AA | ||||
Dose | Table 4 Ethylenediamine (repeat) with S9 activation | ||||
mg/plate | TA100 | TA1535 | |||
0 | 116+14.0 | 16+4.4 | |||
1 | 139+5.3 | 9+2.5 | |||
2 | 148+15.3 | 12+2.5 | |||
3 | 157+28.5 | 16+1.2 | |||
4 | 193+17.9 | 16+6.6 | |||
5 | 201+25.0 | 16+3.6 | |||
6 | 149 S | 14+2.1 | |||
Pos Control | 1564+108.8 | 114+26.2 | |||
2 -AA | 2 -AA | ||||
T-Toxic | |||||
S-Sparse growth of background lawn |
4-NPD: 4-NITRO-0 -PHENYLENEDIAMINE; 9-AA: 9-AMINOACRIDINE;
NaN3: SODIUM AZIDE; 2-AA: 2-AMINOANTHRACENE
+ indicates standard deviation of mean value
Applicant's summary and conclusion
- Conclusions:
- Because of a less than 2-fold increase obtained with TA100 tested with S9, EDA was considered not to be mutagenic in this in vitro bacterial assay. No increases were seen using strains TA 98, TA 1535, 1537 and 1538 with and without metabolic activation.
- Executive summary:
Ethylenediamine (EDA) was tested for potential mutagenic activity using the Salmonella/microsome bacterial mutagenicity assay (Ames test). Test concentrations for the Ames test were chosen from data obtained in a preliminary study with strain TA 100 performed both with and without a rat liver S9 activation system.
In tests without S9, a dose level of 1.0 mg/plate allowed only sparse growth of the background lawn and reduced the numbers of revertant colonies to less than half the control level. In contrast, tests with S9 activation allowed confluent growth of the background lawn at dose levels ranging from 0.01 to 3.0 mg/plate. A slightly higher dose of 5.0 mg/plate allowed only sparse growth of the background lawn. Based on these results, five doses ranging from 0.01 to 1.0 mg/plate were tested in the definitive test without S9 and a higher range of 0.1 to 5 mg/plate was tested in the presence of the S9 metabolic activation system. These concentrations were tested with five different strains of Salmonella typhimurium (TA98, TA100, TA1535, TA1537, and TA1538) using triplicate cultures at each dose level for each strain.
In the definitive mutagenicity test performed without S9, no evidence of positive or dose related mutagenic activity was observed with any of the five strains. In tests performed in the presence of an Aroclor 1254 induced rat-liver S9 metabolic activation system, only strain TA100 showed a slight increase in numbers of revertant colonies (the magnitude of the response at the highest concentration levels ranged from 1.7 to 1.9 times the concurrent controls) but this was less than a 2-fold increase. In the first test with S9, TA1535 showed a slight increase; however, this response was within the historical control range of variation for this strain and was not reproduced in two additional experiments. Overall, because of a less than 2-fold increase obtained with TA100 tested with S9, and no increases were seen using strains TA 98, TA 1535, 1537 and 1538 with and without metabolic activation, EDA was considered not to be mutagenic in this in vitro bacterial assay.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.